The Enhanced Blue Fluorescent Protein (EBFP) is a sophisticated tool in molecular biology, crafted through the modification of the green fluorescent protein (GFP) which was originally found in the bioluminescent jellyfish Aequorea victoria. EBFP has been engineered to exhibit enhanced fluorescence and stability compared to its predecessor, making it an invaluable asset for a range of applications in research. Its vivid blue fluorescence allows for the visualization and tracking of gene expression, protein localization, and cell lineage tracing in real-time. The utility of EBFP lies in its ability to act as a reporter gene; it can be inserted into the DNA of cells, and when these cells express EBFP, they emit a distinctive blue glow under specific lighting conditions. This property is exploited to study gene expression patterns, cellular processes, and the interactions between biological molecules.
To induce the expression of EBFP in a controlled and efficient manner, researchers employ various chemical activators that interact with the regulatory elements controlling the EBFP gene. These chemicals are not simply random selections but are chosen based on their ability to interact with specific promoter sequences that have been engineered to respond to them. For instance, substances like tetracycline or its analog doxycycline can be used to activate tetracycline-responsive promoters, which, in turn, stimulate the expression of EBFP. Similarly, the sugar rhamnose or the small molecule IPTG (Isopropyl β-D-1-thiogalactopyranoside) may be utilized to selectively trigger promoters that are designed to respond to these inducers. The process involves the binding of these molecules to the promoter, which then initiates the transcription of the EBFP gene, resulting in the production of the fluorescent protein. Through careful design and implementation of such systems, researchers can achieve precise spatial and temporal control over EBFP expression, enabling them to dissect complex biological phenomena with remarkable clarity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline might upregulate EBFP expression by binding to a repressor that normally inhibits a tetracycline-responsive promoter linked to the EBFP gene. | ||||||
IPTG, Dioxane-Free | 367-93-1 | sc-202185 sc-202185A sc-202185B sc-202185C sc-202185D sc-202185E sc-202185F | 1 g 5 g 100 g 500 g 1 kg 10 kg 25 kg | $51.00 $117.00 $510.00 $1785.00 $2240.00 $16646.00 $32773.00 | 27 | |
IPTG can trigger the expression of EBFP by mimicking the natural inducer of the lac operon, leading to the activation of an IPTG-inducible promoter upstream of the EBFP gene. | ||||||
Doxycycline-d6 | 564-25-0 unlabeled | sc-218274 | 1 mg | $16500.00 | ||
Doxycycline could stimulate EBFP production by activating a Tet-On promoter; this promoter only initiates transcription in the presence of doxycycline, allowing for precise control of EBFP levels. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone has the potential to increase EBFP expression by acting on a synthetic promoter containing hormone-responsive elements that activate transcription in its presence. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is capable of stimulating EBFP synthesis if the gene is placed under the control of a promoter containing glucocorticoid response elements that respond to this compound. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol may enhance the transcription of the EBFP gene by binding to estrogen receptors that interact with an estrogen-responsive promoter controlling EBFP expression. | ||||||
Anhydrotetracycline | 1665-56-1 | sc-481048 | 2.5 mg | $320.00 | ||
Anhydrotetracycline could initiate the transcription of the EBFP gene by binding to and deactivating a repressor protein that inhibits a specially designed anhydrotetracycline-responsive promoter. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin might upregulate EBFP expression in a system where a promoter is activated by statin-like molecules, potentially linked to pathways that respond to cholesterol-lowering drugs. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin can stimulate the expression of EBFP if engineered alongside a promoter that is activated by the binding of this compound, utilized in certain antibiotic response studies. | ||||||
Vitamin B1 | 59-43-8 | sc-338735 | 5 g | $611.00 | ||
Vitamin B1 might act as an inducer of EBFP expression when linked to a thiamine-responsive promoter, a system that could be used in yeast or other eukaryotic cells. | ||||||